Linda Ashcroft
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Epidemiology top 10%
- Genetics top 10%
- Co-authors
- Paul LoriganN. ThatcherFiona BlackhallCorinne Faivre‐FinnRichard BootonM. SneeAnthony HowellD. Gareth Evans
- Topics
- Lung Cancer Research Studies (25 papers)Lung Cancer Treatments and Mutations (17 papers)Lung Cancer Diagnosis and Treatment (15 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Linda Ashcroft
58 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 1.2k
- Pulmonary and Respiratory Medicine 717
- Molecular Biology 443
- Epidemiology 424
- Genetics 260
Countries citing papers authored by Linda Ashcroft
This map shows the geographic impact of Linda Ashcroft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Ashcroft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Ashcroft more than expected).
Fields of papers citing papers by Linda Ashcroft
This network shows the impact of papers produced by Linda Ashcroft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Ashcroft. The network helps show where Linda Ashcroft may publish in the future.
Co-authorship network of co-authors of Linda Ashcroft
This figure shows the co-authorship network connecting the top 25 collaborators of Linda Ashcroft. A scholar is included among the top collaborators of Linda Ashcroft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Ashcroft. Linda Ashcroft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 16 | |
| 6 | 30 | |
| 7 | 4 | |
| 8 | 29 | |
| 9 | 15 | |
| 10 | 93 | |
| 11 | 34 | |
| 12 | 90 | |
| 13 | 2 | |
| 14 | 41 | |
| 15 | 51 | |
| 16 | 19 | |
| 17 | 86 | |
| 18 | 22 | |
| 19 | 23 | |
| 20 | 3 |
About Linda Ashcroft
Linda Ashcroft is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 59 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (25 papers), Lung Cancer Treatments and Mutations (17 papers) and Lung Cancer Diagnosis and Treatment (15 papers). The work is most often cited by research in Oncology (1.2k citations), Pulmonary and Respiratory Medicine (717 citations) and Cancer Research (249 citations). Linda Ashcroft has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Paul Lorigan, N. Thatcher, Fiona Blackhall, Corinne Faivre‐Finn, Richard Booton, M. Snee, Anthony Howell, D. Gareth Evans, Penella J. Woll and Mary O’Brien. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.